Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 7.61637666 |
2 | Golgi transport vesicle coating (GO:0048200) | 7.61637666 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.60165674 |
4 | protein retention in ER lumen (GO:0006621) | 6.21325621 |
5 | signal peptide processing (GO:0006465) | 5.68748609 |
6 | proteasome assembly (GO:0043248) | 4.82522331 |
7 | COPII vesicle coating (GO:0048208) | 4.47116912 |
8 | keratan sulfate catabolic process (GO:0042340) | 4.28411309 |
9 | collagen fibril organization (GO:0030199) | 4.27478486 |
10 | chondrocyte development (GO:0002063) | 4.01820662 |
11 | chondrocyte proliferation (GO:0035988) | 3.98495304 |
12 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.67576829 |
13 | ribosome assembly (GO:0042255) | 3.67084059 |
14 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.63919702 |
15 | positive regulation of actin filament depolymerization (GO:0030836) | 3.55525493 |
16 | exocrine pancreas development (GO:0031017) | 3.43984205 |
17 | regulation of metalloenzyme activity (GO:0048552) | 3.42976726 |
18 | lipid particle organization (GO:0034389) | 3.38199451 |
19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.38181260 |
20 | tRNA aminoacylation for protein translation (GO:0006418) | 3.35452358 |
21 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.33440604 |
22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32897001 |
23 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.24497389 |
24 | dermatan sulfate biosynthetic process (GO:0030208) | 3.23421975 |
25 | amino acid activation (GO:0043038) | 3.23312388 |
26 | tRNA aminoacylation (GO:0043039) | 3.23312388 |
27 | establishment of viral latency (GO:0019043) | 3.20413936 |
28 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.19695816 |
29 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.19429113 |
30 | vesicle coating (GO:0006901) | 3.18815849 |
31 | platelet dense granule organization (GO:0060155) | 3.18271067 |
32 | cellular response to vitamin D (GO:0071305) | 3.17718949 |
33 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.15643593 |
34 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.12102397 |
35 | negative regulation of ligase activity (GO:0051352) | 3.12102397 |
36 | cholesterol biosynthetic process (GO:0006695) | 3.09631466 |
37 | dermatan sulfate metabolic process (GO:0030205) | 3.04162702 |
38 | sterol biosynthetic process (GO:0016126) | 2.99780014 |
39 | type B pancreatic cell proliferation (GO:0044342) | 2.97332740 |
40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.96558750 |
41 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.96401378 |
42 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.92954354 |
43 | peptidyl-asparagine modification (GO:0018196) | 2.90724279 |
44 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.88877229 |
45 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.88877229 |
46 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.88517859 |
47 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.87439873 |
48 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.87439873 |
49 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.87439873 |
50 | fatty acid elongation (GO:0030497) | 2.86825865 |
51 | cartilage condensation (GO:0001502) | 2.85743400 |
52 | cell aggregation (GO:0098743) | 2.85743400 |
53 | positive regulation of nuclease activity (GO:0032075) | 2.84419210 |
54 | viral protein processing (GO:0019082) | 2.83333653 |
55 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.81491968 |
56 | cullin deneddylation (GO:0010388) | 2.81349472 |
57 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.81114120 |
58 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.81049753 |
59 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80572224 |
60 | protein neddylation (GO:0045116) | 2.80345135 |
61 | membrane budding (GO:0006900) | 2.79622113 |
62 | response to redox state (GO:0051775) | 2.79016334 |
63 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.77893591 |
64 | endothelial cell morphogenesis (GO:0001886) | 2.77243118 |
65 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.73978202 |
66 | peptidyl-histidine modification (GO:0018202) | 2.73872712 |
67 | cellular response to unfolded protein (GO:0034620) | 2.73352177 |
68 | 4-hydroxyproline metabolic process (GO:0019471) | 2.72508001 |
69 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71867199 |
70 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71867199 |
71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.71162115 |
72 | protein heterotrimerization (GO:0070208) | 2.70719287 |
73 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.70719043 |
74 | ER overload response (GO:0006983) | 2.70593858 |
75 | protein N-linked glycosylation (GO:0006487) | 2.70070962 |
76 | peptidyl-proline hydroxylation (GO:0019511) | 2.69736071 |
77 | collagen metabolic process (GO:0032963) | 2.68193860 |
78 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.67647708 |
79 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.67221175 |
80 | L-serine transport (GO:0015825) | 2.66898830 |
81 | virion assembly (GO:0019068) | 2.66376293 |
82 | DNA damage response, detection of DNA damage (GO:0042769) | 2.65855043 |
83 | regulation of nuclease activity (GO:0032069) | 2.65831077 |
84 | mannosylation (GO:0097502) | 2.65750796 |
85 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.65678775 |
86 | positive regulation of ligase activity (GO:0051351) | 2.65362918 |
87 | fibril organization (GO:0097435) | 2.65071021 |
88 | cellular response to vitamin (GO:0071295) | 2.64531449 |
89 | positive regulation of extracellular matrix organization (GO:1903055) | 2.64420312 |
90 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.63918275 |
91 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.61992364 |
92 | skin morphogenesis (GO:0043589) | 2.61913739 |
93 | protein deneddylation (GO:0000338) | 2.61732921 |
94 | mesenchyme morphogenesis (GO:0072132) | 2.61408778 |
95 | cellular response to topologically incorrect protein (GO:0035967) | 2.60737603 |
96 | collagen catabolic process (GO:0030574) | 2.60352477 |
97 | cell adhesion mediated by integrin (GO:0033627) | 2.59903052 |
98 | de novo protein folding (GO:0006458) | 2.59827953 |
99 | peptidyl-cysteine modification (GO:0018198) | 2.58018146 |
100 | notochord development (GO:0030903) | 2.57060599 |
101 | protein K11-linked ubiquitination (GO:0070979) | 2.56878104 |
102 | protein maturation by protein folding (GO:0022417) | 2.56234385 |
103 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.55637210 |
104 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.55460466 |
105 | positive regulation of cartilage development (GO:0061036) | 2.54738601 |
106 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.54369404 |
107 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.54204583 |
108 | aldehyde catabolic process (GO:0046185) | 2.54163614 |
109 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.52996353 |
110 | tricarboxylic acid cycle (GO:0006099) | 2.52535298 |
111 | multicellular organismal catabolic process (GO:0044243) | 2.52389346 |
112 | ER-nucleus signaling pathway (GO:0006984) | 2.51901104 |
113 | regulation of cofactor metabolic process (GO:0051193) | 2.51809068 |
114 | regulation of coenzyme metabolic process (GO:0051196) | 2.51809068 |
115 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.51572215 |
116 | endodermal cell differentiation (GO:0035987) | 2.51254028 |
117 | negative regulation of cartilage development (GO:0061037) | 2.50671213 |
118 | regulation of interleukin-8 secretion (GO:2000482) | 2.50095575 |
119 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.49550229 |
120 | de novo posttranslational protein folding (GO:0051084) | 2.49328611 |
121 | ventricular cardiac muscle cell development (GO:0055015) | 2.48716394 |
122 | extracellular fibril organization (GO:0043206) | 2.47738625 |
123 | extracellular matrix disassembly (GO:0022617) | 2.46842511 |
124 | positive regulation of mitochondrial fission (GO:0090141) | 2.46621693 |
125 | amino acid salvage (GO:0043102) | 2.45497026 |
126 | L-methionine salvage (GO:0071267) | 2.45497026 |
127 | L-methionine biosynthetic process (GO:0071265) | 2.45497026 |
128 | multicellular organismal metabolic process (GO:0044236) | 2.45484081 |
129 | nucleotide-sugar metabolic process (GO:0009225) | 2.45249381 |
130 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.45146591 |
131 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.44423367 |
132 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.43792382 |
133 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.43792382 |
134 | establishment of integrated proviral latency (GO:0075713) | 2.43551447 |
135 | sequestering of metal ion (GO:0051238) | 2.42542894 |
136 | C-terminal protein amino acid modification (GO:0018410) | 2.42384369 |
137 | regulation of ligase activity (GO:0051340) | 2.42117890 |
138 | mesodermal cell differentiation (GO:0048333) | 2.41876803 |
139 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.41860302 |
140 | neural crest cell development (GO:0014032) | 2.41573885 |
141 | DNA double-strand break processing (GO:0000729) | 2.40927084 |
142 | nucleotide transmembrane transport (GO:1901679) | 2.39933765 |
143 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.38804121 |
144 | peptidyl-proline modification (GO:0018208) | 2.36397072 |
145 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.35901678 |
146 | protein refolding (GO:0042026) | 2.35831216 |
147 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.35041028 |
148 | C-terminal protein lipidation (GO:0006501) | 2.34762828 |
149 | negative regulation of protein ubiquitination (GO:0031397) | 2.33815861 |
150 | 7-methylguanosine mRNA capping (GO:0006370) | 2.33168944 |
151 | response to endoplasmic reticulum stress (GO:0034976) | 2.33039387 |
152 | regulation of cellular amine metabolic process (GO:0033238) | 2.32025474 |
153 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.31967093 |
154 | chaperone-mediated protein folding (GO:0061077) | 2.31697678 |
155 | cell proliferation involved in kidney development (GO:0072111) | 2.31502870 |
156 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.31363016 |
157 | response to hepatocyte growth factor (GO:0035728) | 2.31363016 |
158 | wound healing, spreading of epidermal cells (GO:0035313) | 2.31245609 |
159 | negative regulation of stem cell proliferation (GO:2000647) | 2.30125792 |
160 | bone trabecula formation (GO:0060346) | 2.30023851 |
161 | limb bud formation (GO:0060174) | 2.29266985 |
162 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.28818830 |
163 | endocardial cushion morphogenesis (GO:0003203) | 2.27781319 |
164 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.25677825 |
165 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.23285616 |
166 | cartilage development (GO:0051216) | 2.22758898 |
167 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.22250277 |
168 | extracellular matrix organization (GO:0030198) | 2.21057409 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.21026336 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.85440572 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.65250373 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.45893023 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43564758 |
6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.38635092 |
7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.06324454 |
8 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.97343896 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.88573727 |
10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.85665564 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58457221 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57377837 |
13 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.45040106 |
14 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.21725336 |
15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.20422665 |
16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19397266 |
17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10036970 |
18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.08214202 |
19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07777708 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07717109 |
21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.05585593 |
22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.04824340 |
23 | CJUN_26792858_Chip-Seq_BT549_Human | 2.03964406 |
24 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.01497273 |
25 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.01010805 |
26 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.98131144 |
27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97720870 |
28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.93286751 |
29 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.90884250 |
30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88730695 |
31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87510370 |
32 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.86282581 |
33 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.85507641 |
34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77205989 |
35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76010261 |
36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75504858 |
37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74992613 |
38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74911247 |
39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73110393 |
40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.68954693 |
41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.68954693 |
42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66753082 |
43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66753082 |
44 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.65115080 |
45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.64155356 |
46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63911351 |
47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63317944 |
48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62812403 |
49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61975102 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57097822 |
51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56973597 |
52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.55786269 |
53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55624330 |
54 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53431270 |
55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53352942 |
56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50853730 |
57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49842801 |
58 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.47575580 |
59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45810274 |
60 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.45406832 |
61 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.44639113 |
62 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.41561887 |
63 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.41493927 |
64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41156048 |
65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40444151 |
66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.39318810 |
67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.38932609 |
68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.38850116 |
69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.36799496 |
70 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.34901767 |
71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.34037051 |
72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.31890304 |
73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31779279 |
74 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30849782 |
75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29380520 |
76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28706683 |
77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27864239 |
78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.26370260 |
79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26047858 |
80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24228449 |
81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24087204 |
82 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23531625 |
83 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23333858 |
84 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23087521 |
85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22924439 |
86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21149150 |
87 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20098178 |
88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19703276 |
89 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19656611 |
90 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19002765 |
91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18951620 |
92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17177346 |
93 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16703265 |
94 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16565909 |
95 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14738196 |
96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12834170 |
97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11747077 |
98 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.11446512 |
99 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.09700077 |
100 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09117230 |
101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08782671 |
102 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.08666655 |
103 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08203381 |
104 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06733356 |
105 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05968935 |
106 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05470439 |
107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05018237 |
108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04477103 |
109 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04361639 |
110 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02312527 |
111 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.02136410 |
112 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01180994 |
113 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00420050 |
114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98834965 |
115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98506852 |
116 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97446433 |
117 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96990934 |
118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96766306 |
119 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96514677 |
120 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96433289 |
121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95156305 |
122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95080512 |
123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94953825 |
124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94557599 |
125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93981869 |
126 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93842142 |
127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93733839 |
128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93554702 |
129 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92905714 |
130 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92811308 |
131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91901472 |
132 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.90986542 |
133 | * NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.90396811 |
134 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.90121315 |
135 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88719379 |
136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88356386 |
137 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88305163 |
138 | * TTF2_22483619_ChIP-Seq_HELA_Human | 0.88014836 |
139 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87076718 |
140 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85740221 |
141 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85062856 |
142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83590017 |
143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83512136 |
144 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82738339 |
145 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.82639003 |
146 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81810867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 5.19623394 |
2 | MP0005503_abnormal_tendon_morphology | 4.64430447 |
3 | MP0005275_abnormal_skin_tensile | 3.24524228 |
4 | MP0006054_spinal_hemorrhage | 2.87822876 |
5 | MP0003950_abnormal_plasma_membrane | 2.75597611 |
6 | MP0004272_abnormal_basement_membrane | 2.59298660 |
7 | MP0009384_cardiac_valve_regurgitation | 2.57542977 |
8 | MP0009250_abnormal_appendicular_skeleto | 2.49143696 |
9 | MP0002102_abnormal_ear_morphology | 2.48542856 |
10 | MP0003279_aneurysm | 2.46132020 |
11 | MP0004134_abnormal_chest_morphology | 2.42983838 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.30180604 |
13 | MP0002282_abnormal_trachea_morphology | 2.22560327 |
14 | MP0001529_abnormal_vocalization | 2.15900725 |
15 | MP0005508_abnormal_skeleton_morphology | 2.14012298 |
16 | MP0002933_joint_inflammation | 2.12519842 |
17 | MP0001542_abnormal_bone_strength | 2.11547603 |
18 | MP0010030_abnormal_orbit_morphology | 2.03623544 |
19 | MP0000163_abnormal_cartilage_morphology | 1.98440111 |
20 | MP0002877_abnormal_melanocyte_morpholog | 1.96514251 |
21 | MP0005220_abnormal_exocrine_pancreas | 1.90652155 |
22 | MP0001958_emphysema | 1.87282836 |
23 | MP0003806_abnormal_nucleotide_metabolis | 1.76647709 |
24 | MP0005084_abnormal_gallbladder_morpholo | 1.73030697 |
25 | MP0002896_abnormal_bone_mineralization | 1.70699647 |
26 | MP0001879_abnormal_lymphatic_vessel | 1.69984638 |
27 | MP0005390_skeleton_phenotype | 1.65571253 |
28 | MP0003385_abnormal_body_wall | 1.64927843 |
29 | MP0002115_abnormal_skeleton_extremities | 1.64167686 |
30 | MP0003942_abnormal_urinary_system | 1.63599230 |
31 | MP0009053_abnormal_anal_canal | 1.62131359 |
32 | MP0002938_white_spotting | 1.59480480 |
33 | MP0002113_abnormal_skeleton_development | 1.57038124 |
34 | MP0008789_abnormal_olfactory_epithelium | 1.54702607 |
35 | MP0004957_abnormal_blastocyst_morpholog | 1.54417728 |
36 | MP0010368_abnormal_lymphatic_system | 1.53697856 |
37 | MP0008932_abnormal_embryonic_tissue | 1.53506021 |
38 | MP0002295_abnormal_pulmonary_circulatio | 1.51296797 |
39 | MP0000049_abnormal_middle_ear | 1.48313039 |
40 | MP0003890_abnormal_embryonic-extraembry | 1.45016647 |
41 | MP0001533_abnormal_skeleton_physiology | 1.37669464 |
42 | MP0002163_abnormal_gland_morphology | 1.37269370 |
43 | MP0003795_abnormal_bone_structure | 1.35850372 |
44 | MP0005023_abnormal_wound_healing | 1.31426692 |
45 | MP0003566_abnormal_cell_adhesion | 1.29145484 |
46 | MP0003122_maternal_imprinting | 1.28480115 |
47 | MP0008058_abnormal_DNA_repair | 1.27033119 |
48 | MP0002060_abnormal_skin_morphology | 1.24209424 |
49 | MP0000678_abnormal_parathyroid_gland | 1.22084823 |
50 | MP0006276_abnormal_autonomic_nervous | 1.21297814 |
51 | MP0003786_premature_aging | 1.20795604 |
52 | MP0010352_gastrointestinal_tract_polyps | 1.19586059 |
53 | MP0001299_abnormal_eye_distance/ | 1.19327740 |
54 | MP0000749_muscle_degeneration | 1.18716592 |
55 | MP0000566_synostosis | 1.16621197 |
56 | MP0002932_abnormal_joint_morphology | 1.16454679 |
57 | MP0005394_taste/olfaction_phenotype | 1.16420929 |
58 | MP0005499_abnormal_olfactory_system | 1.16420929 |
59 | MP0002109_abnormal_limb_morphology | 1.14356566 |
60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14079876 |
61 | MP0000013_abnormal_adipose_tissue | 1.11895615 |
62 | MP0001243_abnormal_dermal_layer | 1.10817274 |
63 | MP0003718_maternal_effect | 1.10740448 |
64 | MP0003755_abnormal_palate_morphology | 1.09656613 |
65 | MP0005171_absent_coat_pigmentation | 1.08544719 |
66 | MP0000516_abnormal_urinary_system | 1.07873559 |
67 | MP0005367_renal/urinary_system_phenotyp | 1.07873559 |
68 | MP0002090_abnormal_vision | 1.07594785 |
69 | MP0000613_abnormal_salivary_gland | 1.06081264 |
70 | MP0005197_abnormal_uvea_morphology | 1.05515851 |
71 | MP0000537_abnormal_urethra_morphology | 1.04684879 |
72 | MP0000358_abnormal_cell_content/ | 1.04439710 |
73 | MP0003693_abnormal_embryo_hatching | 1.04340035 |
74 | MP0003724_increased_susceptibility_to | 1.03467837 |
75 | MP0000767_abnormal_smooth_muscle | 1.03447656 |
76 | MP0001270_distended_abdomen | 1.02014366 |
77 | MP0009780_abnormal_chondrocyte_physiolo | 1.01124615 |
78 | MP0002108_abnormal_muscle_morphology | 1.01035658 |
79 | MP0005257_abnormal_intraocular_pressure | 0.99851303 |
80 | MP0000534_abnormal_ureter_morphology | 0.99373511 |
81 | MP0008007_abnormal_cellular_replicative | 0.98981433 |
82 | MP0002254_reproductive_system_inflammat | 0.98607572 |
83 | MP0000343_altered_response_to | 0.98342985 |
84 | MP0002116_abnormal_craniofacial_bone | 0.98302468 |
85 | MP0000762_abnormal_tongue_morphology | 0.97563427 |
86 | MP0003943_abnormal_hepatobiliary_system | 0.97392568 |
87 | MP0002089_abnormal_postnatal_growth/wei | 0.97246884 |
88 | MP0002084_abnormal_developmental_patter | 0.97211232 |
89 | MP0003123_paternal_imprinting | 0.97133420 |
90 | MP0009697_abnormal_copulation | 0.96880502 |
91 | MP0001348_abnormal_lacrimal_gland | 0.96434162 |
92 | MP0002138_abnormal_hepatobiliary_system | 0.94657350 |
93 | MP0000647_abnormal_sebaceous_gland | 0.94486811 |
94 | MP0005187_abnormal_penis_morphology | 0.94125747 |
95 | MP0002998_abnormal_bone_remodeling | 0.94098377 |
96 | MP0003091_abnormal_cell_migration | 0.94072809 |
97 | MP0000858_altered_metastatic_potential | 0.92748997 |
98 | MP0005379_endocrine/exocrine_gland_phen | 0.92463870 |
99 | MP0003186_abnormal_redox_activity | 0.89488103 |
100 | MP0008004_abnormal_stomach_pH | 0.88921833 |
101 | MP0006072_abnormal_retinal_apoptosis | 0.88821731 |
102 | MP0000372_irregular_coat_pigmentation | 0.88606993 |
103 | MP0001915_intracranial_hemorrhage | 0.88570603 |
104 | MP0005164_abnormal_response_to | 0.88037388 |
105 | MP0004133_heterotaxia | 0.87628340 |
106 | MP0001293_anophthalmia | 0.86139518 |
107 | MP0003937_abnormal_limbs/digits/tail_de | 0.85976593 |
108 | MP0000681_abnormal_thyroid_gland | 0.85619397 |
109 | MP0010386_abnormal_urinary_bladder | 0.85562429 |
110 | MP0001944_abnormal_pancreas_morphology | 0.85410425 |
111 | MP0005360_urolithiasis | 0.84547945 |
112 | MP0000751_myopathy | 0.82890680 |
113 | MP0004782_abnormal_surfactant_physiolog | 0.82002607 |
114 | MP0002751_abnormal_autonomic_nervous | 0.81605191 |
115 | MP0003283_abnormal_digestive_organ | 0.80874734 |
116 | MP0004264_abnormal_extraembryonic_tissu | 0.80600933 |
117 | MP0003868_abnormal_feces_composition | 0.79401479 |
118 | MP0002233_abnormal_nose_morphology | 0.79348597 |
119 | MP0008260_abnormal_autophagy | 0.77503869 |
120 | MP0003115_abnormal_respiratory_system | 0.77241700 |
121 | MP0000432_abnormal_head_morphology | 0.76958590 |
122 | MP0005085_abnormal_gallbladder_physiolo | 0.76733957 |
123 | MP0001346_abnormal_lacrimal_gland | 0.76286970 |
124 | MP0001177_atelectasis | 0.75995818 |
125 | MP0005623_abnormal_meninges_morphology | 0.75988472 |
126 | MP0004215_abnormal_myocardial_fiber | 0.75735244 |
127 | MP0005248_abnormal_Harderian_gland | 0.75645837 |
128 | MP0002177_abnormal_outer_ear | 0.74347935 |
129 | MP0003011_delayed_dark_adaptation | 0.73087231 |
130 | MP0002111_abnormal_tail_morphology | 0.73062186 |
131 | MP0002249_abnormal_larynx_morphology | 0.72562096 |
132 | MP0003941_abnormal_skin_development | 0.72309718 |
133 | MP0005408_hypopigmentation | 0.72023186 |
134 | MP0001175_abnormal_lung_morphology | 0.71949417 |
135 | MP0005253_abnormal_eye_physiology | 0.70310177 |
136 | MP0003935_abnormal_craniofacial_develop | 0.70136438 |
137 | MP0001764_abnormal_homeostasis | 0.69910198 |
138 | MP0002085_abnormal_embryonic_tissue | 0.68985878 |
139 | MP0003448_altered_tumor_morphology | 0.68306466 |
140 | MP0005501_abnormal_skin_physiology | 0.67814693 |
141 | MP0002234_abnormal_pharynx_morphology | 0.67009547 |
142 | MP0000639_abnormal_adrenal_gland | 0.66572607 |
143 | MP0003195_calcinosis | 0.65106373 |
144 | MP0003119_abnormal_digestive_system | 0.64909932 |
145 | MP0001697_abnormal_embryo_size | 0.64901055 |
146 | MP0009379_abnormal_foot_pigmentation | 0.64544656 |
147 | MP0010771_integument_phenotype | 0.61820148 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Epiphyseal dysplasia (HP:0002656) | 5.69776246 |
2 | Irregular epiphyses (HP:0010582) | 4.98395254 |
3 | Protrusio acetabuli (HP:0003179) | 4.80175659 |
4 | Abnormality of glycolysis (HP:0004366) | 4.14333096 |
5 | Vitreoretinal degeneration (HP:0000655) | 4.05168998 |
6 | Increased serum pyruvate (HP:0003542) | 4.03436410 |
7 | Cupped ribs (HP:0000887) | 3.95970244 |
8 | Premature rupture of membranes (HP:0001788) | 3.95019611 |
9 | Cervical subluxation (HP:0003308) | 3.88287001 |
10 | Small epiphyses (HP:0010585) | 3.75327487 |
11 | Upper limb muscle weakness (HP:0003484) | 3.67374630 |
12 | Abnormal tarsal ossification (HP:0008369) | 3.66232199 |
13 | Metaphyseal dysplasia (HP:0100255) | 3.51398959 |
14 | Flat capital femoral epiphysis (HP:0003370) | 3.44395092 |
15 | Delayed epiphyseal ossification (HP:0002663) | 3.40559964 |
16 | Neonatal short-limb short stature (HP:0008921) | 3.37948070 |
17 | Vertebral compression fractures (HP:0002953) | 3.24264573 |
18 | Hand muscle atrophy (HP:0009130) | 3.21316503 |
19 | Beaking of vertebral bodies (HP:0004568) | 3.19638318 |
20 | Hypoplastic ischia (HP:0003175) | 3.13326895 |
21 | Genu varum (HP:0002970) | 3.07129668 |
22 | Abnormality of dentin (HP:0010299) | 3.04952878 |
23 | Platyspondyly (HP:0000926) | 3.01700315 |
24 | Soft skin (HP:0000977) | 3.01573602 |
25 | Abnormal foot bone ossification (HP:0010675) | 2.99456784 |
26 | Reduced antithrombin III activity (HP:0001976) | 2.96320986 |
27 | Osteoarthritis (HP:0002758) | 2.91156772 |
28 | Aortic aneurysm (HP:0004942) | 2.91088197 |
29 | Mild short stature (HP:0003502) | 2.90635171 |
30 | Irregular vertebral endplates (HP:0003301) | 2.90459790 |
31 | Tetraparesis (HP:0002273) | 2.89386521 |
32 | Abnormality of the vertebral endplates (HP:0005106) | 2.88241300 |
33 | Metaphyseal cupping (HP:0003021) | 2.86785051 |
34 | Delayed gross motor development (HP:0002194) | 2.84917407 |
35 | Wormian bones (HP:0002645) | 2.78155388 |
36 | Thoracolumbar scoliosis (HP:0002944) | 2.76791529 |
37 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.76344034 |
38 | Coxa vara (HP:0002812) | 2.74346022 |
39 | Abnormality of the ischium (HP:0003174) | 2.72799236 |
40 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.68296099 |
41 | Abnormality of femoral epiphyses (HP:0006499) | 2.68296099 |
42 | Vascular tortuosity (HP:0004948) | 2.66923797 |
43 | Flattened epiphyses (HP:0003071) | 2.66294396 |
44 | Aortic dissection (HP:0002647) | 2.66054259 |
45 | Flat acetabular roof (HP:0003180) | 2.65581076 |
46 | Biconcave vertebral bodies (HP:0004586) | 2.59804214 |
47 | Abnormality of the anterior horn cell (HP:0006802) | 2.56809937 |
48 | Degeneration of anterior horn cells (HP:0002398) | 2.56809937 |
49 | Postnatal microcephaly (HP:0005484) | 2.54127055 |
50 | Congenital primary aphakia (HP:0007707) | 2.54119226 |
51 | Abnormality of the acetabulum (HP:0003170) | 2.53376037 |
52 | Medial flaring of the eyebrow (HP:0010747) | 2.48925774 |
53 | Abnormality of carpal bone ossification (HP:0006257) | 2.47806531 |
54 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.44046061 |
55 | Methylmalonic acidemia (HP:0002912) | 2.42207098 |
56 | Abnormal gallbladder physiology (HP:0012438) | 2.39053384 |
57 | Cholecystitis (HP:0001082) | 2.39053384 |
58 | Abnormality of the femoral head (HP:0003368) | 2.38478453 |
59 | Distal upper limb amyotrophy (HP:0007149) | 2.38286033 |
60 | Upper limb amyotrophy (HP:0009129) | 2.38286033 |
61 | Gait imbalance (HP:0002141) | 2.37664080 |
62 | Hepatoblastoma (HP:0002884) | 2.31623043 |
63 | Disproportionate short-trunk short stature (HP:0003521) | 2.29881989 |
64 | Joint stiffness (HP:0001387) | 2.29850213 |
65 | Follicular hyperkeratosis (HP:0007502) | 2.29403694 |
66 | Hypoplastic pelvis (HP:0008839) | 2.28614252 |
67 | Nephrogenic diabetes insipidus (HP:0009806) | 2.28376099 |
68 | Blue sclerae (HP:0000592) | 2.28286567 |
69 | Abnormal pancreas size (HP:0012094) | 2.27763597 |
70 | Acute necrotizing encephalopathy (HP:0006965) | 2.25354485 |
71 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.25191400 |
72 | Absent epiphyses (HP:0010577) | 2.25191400 |
73 | Abnormality of incisor morphology (HP:0011063) | 2.21795333 |
74 | Enlarged epiphyses (HP:0010580) | 2.20562890 |
75 | Metaphyseal irregularity (HP:0003025) | 2.18392012 |
76 | Arterial tortuosity (HP:0005116) | 2.16419561 |
77 | Vertebral hypoplasia (HP:0008417) | 2.15414431 |
78 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.15414431 |
79 | Hypoplasia of the odontoid process (HP:0003311) | 2.14488962 |
80 | Acute encephalopathy (HP:0006846) | 2.13608108 |
81 | Glossoptosis (HP:0000162) | 2.13458954 |
82 | Exostoses (HP:0100777) | 2.12653061 |
83 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11561848 |
84 | Short femoral neck (HP:0100864) | 2.10070394 |
85 | Redundant skin (HP:0001582) | 2.09650045 |
86 | Mesomelia (HP:0003027) | 2.09509988 |
87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08336179 |
88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08336179 |
89 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.07824939 |
90 | Type I transferrin isoform profile (HP:0003642) | 2.07118122 |
91 | Abnormal vertebral ossification (HP:0100569) | 2.06528621 |
92 | Dilatation of the ascending aorta (HP:0005111) | 2.05349167 |
93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05030303 |
94 | Abnormality of alanine metabolism (HP:0010916) | 2.05030303 |
95 | Hyperalaninemia (HP:0003348) | 2.05030303 |
96 | Abnormal protein glycosylation (HP:0012346) | 2.04958012 |
97 | Abnormal glycosylation (HP:0012345) | 2.04958012 |
98 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.04958012 |
99 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.04958012 |
100 | Atrophic scars (HP:0001075) | 2.04514846 |
101 | Abnormality of methionine metabolism (HP:0010901) | 2.03949190 |
102 | Ovoid vertebral bodies (HP:0003300) | 2.03578859 |
103 | Methylmalonic aciduria (HP:0012120) | 2.03450027 |
104 | Intrahepatic cholestasis (HP:0001406) | 2.01174117 |
105 | Secondary amenorrhea (HP:0000869) | 2.00039267 |
106 | Spondylolisthesis (HP:0003302) | 1.99260007 |
107 | Decreased skull ossification (HP:0004331) | 1.98660525 |
108 | Spinal cord compression (HP:0002176) | 1.98322276 |
109 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.97785734 |
110 | Micromelia (HP:0002983) | 1.96870308 |
111 | Increased CSF lactate (HP:0002490) | 1.95151984 |
112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95085621 |
113 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.95044416 |
114 | Broad long bones (HP:0005622) | 1.94261195 |
115 | Abnormal hand bone ossification (HP:0010660) | 1.93806972 |
116 | Vaginal atresia (HP:0000148) | 1.92979003 |
117 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.92889897 |
118 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.92314150 |
119 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.92314150 |
120 | Genital tract atresia (HP:0001827) | 1.92162756 |
121 | Abnormal cartilage morphology (HP:0002763) | 1.91132585 |
122 | Shoulder girdle muscle weakness (HP:0003547) | 1.90081082 |
123 | Hepatocellular necrosis (HP:0001404) | 1.89799530 |
124 | Proximal tubulopathy (HP:0000114) | 1.89692215 |
125 | Hepatic necrosis (HP:0002605) | 1.89621305 |
126 | Abnormal ossification of hand bones (HP:0005921) | 1.88886422 |
127 | Patchy hypopigmentation of hair (HP:0011365) | 1.88302954 |
128 | Overgrowth (HP:0001548) | 1.88002872 |
129 | Protuberant abdomen (HP:0001538) | 1.87004609 |
130 | Progressive macrocephaly (HP:0004481) | 1.86737084 |
131 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.86500235 |
132 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.86400459 |
133 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.86400459 |
134 | Single umbilical artery (HP:0001195) | 1.86400459 |
135 | Bifid tongue (HP:0010297) | 1.86171348 |
136 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.85311266 |
137 | Arthropathy (HP:0003040) | 1.83858056 |
138 | Abnormality of the odontoid process (HP:0003310) | 1.83783665 |
139 | Ankle contracture (HP:0006466) | 1.83711349 |
140 | Broad phalanx (HP:0006009) | 1.83527491 |
141 | Neonatal respiratory distress (HP:0002643) | 1.82731850 |
142 | Spinal rigidity (HP:0003306) | 1.82484732 |
143 | Peritonitis (HP:0002586) | 1.82313446 |
144 | Bladder diverticulum (HP:0000015) | 1.81752414 |
145 | Shallow orbits (HP:0000586) | 1.81359823 |
146 | Coxa valga (HP:0002673) | 1.80975642 |
147 | Decreased testicular size (HP:0008734) | 1.79852043 |
148 | Entropion (HP:0000621) | 1.79553259 |
149 | Hypothermia (HP:0002045) | 1.78602238 |
150 | Short nail (HP:0001799) | 1.78500541 |
151 | Cerebral hypomyelination (HP:0006808) | 1.78485519 |
152 | Ectopia lentis (HP:0001083) | 1.76847529 |
153 | Abnormal delivery (HP:0001787) | 1.75521737 |
154 | Wide anterior fontanel (HP:0000260) | 1.74618931 |
155 | Tongue fasciculations (HP:0001308) | 1.73618649 |
156 | Cortical dysplasia (HP:0002539) | 1.72726120 |
157 | Abnormality of the umbilical cord (HP:0010881) | 1.72504272 |
158 | Cerebral edema (HP:0002181) | 1.71158997 |
159 | Microglossia (HP:0000171) | 1.70812067 |
160 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.69783121 |
161 | Stenosis of the external auditory canal (HP:0000402) | 1.69567828 |
162 | Short tibia (HP:0005736) | 1.69339684 |
163 | Hydroxyprolinuria (HP:0003080) | 1.67626716 |
164 | Abnormality of proline metabolism (HP:0010907) | 1.67626716 |
165 | Broad foot (HP:0001769) | 1.65457302 |
166 | Limb-girdle muscle atrophy (HP:0003797) | 1.65115633 |
167 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.64890036 |
168 | Mitochondrial inheritance (HP:0001427) | 1.64686309 |
169 | Increased serum lactate (HP:0002151) | 1.63686912 |
170 | Poor head control (HP:0002421) | 1.59983399 |
171 | Generalized aminoaciduria (HP:0002909) | 1.58121058 |
172 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.57172220 |
173 | Adrenal hypoplasia (HP:0000835) | 1.56978148 |
174 | Abnormality of the labia (HP:0000058) | 1.56877526 |
175 | Abnormality of serum amino acid levels (HP:0003112) | 1.56846009 |
176 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.56479152 |
177 | Keratoconus (HP:0000563) | 1.54787951 |
178 | Increased corneal curvature (HP:0100692) | 1.54787951 |
179 | Abnormality of the intrinsic pathway (HP:0010989) | 1.54653724 |
180 | Poor suck (HP:0002033) | 1.53461600 |
181 | Nonimmune hydrops fetalis (HP:0001790) | 1.53446518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28 | 4.19578472 |
2 | ERBB3 | 3.52398634 |
3 | MAP4K2 | 3.36157850 |
4 | TESK1 | 3.15711156 |
5 | LIMK1 | 2.76645428 |
6 | EPHA3 | 2.58687654 |
7 | PIM2 | 2.51040541 |
8 | MAP3K3 | 2.49131988 |
9 | DDR2 | 2.45247385 |
10 | MAP3K12 | 2.44502228 |
11 | ERN1 | 2.09653492 |
12 | FRK | 2.08137255 |
13 | RPS6KA4 | 2.06967045 |
14 | NEK1 | 1.98430535 |
15 | PDK2 | 1.98393670 |
16 | PASK | 1.94658693 |
17 | TGFBR1 | 1.85995632 |
18 | IRAK1 | 1.85678018 |
19 | EIF2AK3 | 1.80882465 |
20 | NUAK1 | 1.76425253 |
21 | STK38L | 1.74882820 |
22 | MST4 | 1.73036851 |
23 | WNK3 | 1.72122548 |
24 | LATS1 | 1.67486050 |
25 | NEK9 | 1.64192578 |
26 | BRSK2 | 1.63061209 |
27 | BCR | 1.54026740 |
28 | EPHB2 | 1.52534641 |
29 | NME2 | 1.51095448 |
30 | IRAK4 | 1.48786264 |
31 | EIF2AK1 | 1.48089332 |
32 | MAPK15 | 1.48018039 |
33 | ACVR1B | 1.46898695 |
34 | MKNK1 | 1.44743390 |
35 | ERBB4 | 1.39711847 |
36 | BMPR1B | 1.32941487 |
37 | TBK1 | 1.31074429 |
38 | MAP3K14 | 1.27632810 |
39 | INSRR | 1.26572640 |
40 | PBK | 1.24227515 |
41 | EPHA2 | 1.20929761 |
42 | PTK2 | 1.20311188 |
43 | SIK3 | 1.19938495 |
44 | PIK3CG | 1.19221117 |
45 | CSNK1G3 | 1.18215489 |
46 | DYRK2 | 1.16362120 |
47 | FLT3 | 1.16241389 |
48 | TESK2 | 1.14876764 |
49 | TTK | 1.14025994 |
50 | CSNK1G1 | 1.12357519 |
51 | CHUK | 1.11538403 |
52 | MYLK | 1.10826509 |
53 | CSNK1A1L | 1.09604117 |
54 | NLK | 1.09275702 |
55 | WEE1 | 1.06013665 |
56 | PRKG2 | 1.05621519 |
57 | TAOK2 | 1.03856390 |
58 | KDR | 1.01554767 |
59 | STK24 | 1.00082166 |
60 | IRAK3 | 0.97985358 |
61 | JAK3 | 0.97258122 |
62 | FER | 0.93956073 |
63 | CSNK1G2 | 0.92604285 |
64 | VRK1 | 0.91950856 |
65 | MST1R | 0.91209413 |
66 | IRAK2 | 0.88522469 |
67 | PLK4 | 0.85850277 |
68 | MAP3K5 | 0.85784331 |
69 | IKBKB | 0.85498130 |
70 | DYRK3 | 0.85225163 |
71 | PAK2 | 0.84982782 |
72 | VRK2 | 0.83953409 |
73 | MET | 0.83849114 |
74 | PLK2 | 0.83021300 |
75 | PRKCE | 0.83008312 |
76 | PIK3CA | 0.82814371 |
77 | PDGFRA | 0.80048452 |
78 | CDK8 | 0.79290766 |
79 | MKNK2 | 0.79260245 |
80 | TGFBR2 | 0.77215325 |
81 | TRIB3 | 0.74083176 |
82 | PAK3 | 0.73983471 |
83 | STK3 | 0.73964591 |
84 | PLK1 | 0.72659118 |
85 | STK16 | 0.72523691 |
86 | DYRK1B | 0.72479039 |
87 | GRK1 | 0.71700299 |
88 | IKBKE | 0.71669878 |
89 | LMTK2 | 0.71240182 |
90 | MINK1 | 0.70760525 |
91 | EIF2AK2 | 0.70690078 |
92 | MAPKAPK5 | 0.70066479 |
93 | TRPM7 | 0.69990854 |
94 | PLK3 | 0.68570936 |
95 | ROCK1 | 0.66277694 |
96 | TEC | 0.65181491 |
97 | KSR1 | 0.63969504 |
98 | MAPK13 | 0.63270761 |
99 | SRPK1 | 0.61999066 |
100 | BUB1 | 0.61615364 |
101 | LRRK2 | 0.61102405 |
102 | PAK4 | 0.60681532 |
103 | ILK | 0.59901538 |
104 | ABL2 | 0.59881374 |
105 | RPS6KB2 | 0.59480306 |
106 | FGFR1 | 0.59400334 |
107 | BCKDK | 0.59382067 |
108 | NME1 | 0.56865623 |
109 | BRSK1 | 0.56150277 |
110 | TNIK | 0.55726689 |
111 | PTK6 | 0.55458905 |
112 | MAP2K7 | 0.55178329 |
113 | STK39 | 0.55026109 |
114 | ZAK | 0.51938108 |
115 | MAP2K2 | 0.50303036 |
116 | AKT3 | 0.47546432 |
117 | TSSK6 | 0.47537760 |
118 | SCYL2 | 0.47030322 |
119 | MAP3K4 | 0.46872840 |
120 | ROCK2 | 0.45846459 |
121 | SIK1 | 0.44405192 |
122 | NEK6 | 0.43777732 |
123 | MAPKAPK2 | 0.43448132 |
124 | ADRBK2 | 0.42559485 |
125 | EPHB1 | 0.42219601 |
126 | LATS2 | 0.41991711 |
127 | PNCK | 0.41580494 |
128 | ADRBK1 | 0.40854297 |
129 | MAPKAPK3 | 0.40434275 |
130 | TIE1 | 0.40433949 |
131 | CASK | 0.39709581 |
132 | IGF1R | 0.38141868 |
133 | ZAP70 | 0.37572504 |
134 | MAP3K11 | 0.36979864 |
135 | MAP3K2 | 0.36305951 |
136 | MAP2K1 | 0.36171746 |
137 | CDK14 | 0.35687880 |
138 | CDK18 | 0.34472206 |
139 | CSNK2A1 | 0.33058216 |
140 | OXSR1 | 0.31785949 |
141 | CDK6 | 0.31428852 |
142 | PTK2B | 0.31078998 |
143 | GSK3A | 0.28673315 |
144 | GRK7 | 0.27594185 |
145 | PAK1 | 0.27262017 |
146 | STK38 | 0.26927986 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 5.51640199 |
2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.92900437 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.88051943 |
4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.52612962 |
5 | Proteasome_Homo sapiens_hsa03050 | 2.49085624 |
6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.40476326 |
7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.34610606 |
8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26542828 |
9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13677510 |
10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.12857246 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.11608501 |
12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05275990 |
13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.03181832 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95495177 |
15 | Legionellosis_Homo sapiens_hsa05134 | 1.90289423 |
16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.89083572 |
17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.83865669 |
18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.78281190 |
19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76395887 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65358572 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46054909 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45643636 |
23 | Focal adhesion_Homo sapiens_hsa04510 | 1.44200318 |
24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42299688 |
25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.42171845 |
26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.40924800 |
27 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.40636480 |
28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40329461 |
29 | Malaria_Homo sapiens_hsa05144 | 1.38744597 |
30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34431992 |
31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.33759960 |
32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31909858 |
33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.30039527 |
34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28486296 |
35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26980228 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.25975665 |
37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25399928 |
38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25046176 |
39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23001443 |
40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.20906113 |
41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17532012 |
42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.14902904 |
43 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.14478956 |
44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11845025 |
45 | Adherens junction_Homo sapiens_hsa04520 | 1.11636232 |
46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10189095 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09876541 |
48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09086939 |
49 | Phagosome_Homo sapiens_hsa04145 | 1.08584216 |
50 | Ribosome_Homo sapiens_hsa03010 | 1.07690323 |
51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01982706 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01873129 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99511600 |
54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98118329 |
55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97342480 |
56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.96306665 |
57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94898458 |
58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94215826 |
59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93399848 |
60 | RNA degradation_Homo sapiens_hsa03018 | 0.91357997 |
61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91246251 |
62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.90348682 |
63 | Peroxisome_Homo sapiens_hsa04146 | 0.90155366 |
64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89250461 |
65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88721899 |
66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88656469 |
67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88600121 |
68 | Prostate cancer_Homo sapiens_hsa05215 | 0.87407772 |
69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86904519 |
70 | Cell cycle_Homo sapiens_hsa04110 | 0.86820277 |
71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86442027 |
72 | Apoptosis_Homo sapiens_hsa04210 | 0.85767245 |
73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84853776 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84815055 |
75 | Measles_Homo sapiens_hsa05162 | 0.84543143 |
76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84162654 |
77 | Bladder cancer_Homo sapiens_hsa05219 | 0.84048157 |
78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82980055 |
79 | Hepatitis B_Homo sapiens_hsa05161 | 0.81440374 |
80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81408846 |
81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79996523 |
82 | Pertussis_Homo sapiens_hsa05133 | 0.79614490 |
83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79012862 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78252913 |
85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77957691 |
86 | Spliceosome_Homo sapiens_hsa03040 | 0.77169665 |
87 | Allograft rejection_Homo sapiens_hsa05330 | 0.75897865 |
88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75184540 |
89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74103309 |
90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73739149 |
91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73602884 |
92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73057219 |
93 | RNA polymerase_Homo sapiens_hsa03020 | 0.72991715 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72079664 |
95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69725893 |
96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69692144 |
97 | Amoebiasis_Homo sapiens_hsa05146 | 0.68539957 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68057351 |
99 | Mismatch repair_Homo sapiens_hsa03430 | 0.67709756 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67407220 |
101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66933795 |
102 | Influenza A_Homo sapiens_hsa05164 | 0.66729760 |
103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65199069 |
104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65187408 |
105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65100289 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64105392 |
107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62373024 |
108 | Base excision repair_Homo sapiens_hsa03410 | 0.61709022 |
109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61312043 |
110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61185682 |
111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60289298 |
112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59507261 |
113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59492571 |
114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59037305 |
115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58537148 |
116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58185774 |
117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57872444 |
118 | Lysosome_Homo sapiens_hsa04142 | 0.57702090 |
119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57430656 |
120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57374848 |
121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57227160 |
122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56947241 |
123 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56755807 |
124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55566629 |
125 | RNA transport_Homo sapiens_hsa03013 | 0.55058918 |
126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53682423 |
127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53219346 |
128 | Purine metabolism_Homo sapiens_hsa00230 | 0.51704378 |
129 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50989311 |
130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50944709 |
131 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50419203 |
132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50192127 |
133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49823730 |
134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49721741 |
135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49320764 |
136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48813838 |
137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48677752 |
138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46433655 |
139 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46167502 |
140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44913966 |
141 | Hepatitis C_Homo sapiens_hsa05160 | 0.44793658 |
142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43910549 |
143 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43171303 |
144 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43162004 |
145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42989262 |
146 | Phototransduction_Homo sapiens_hsa04744 | 0.42168964 |
147 | Melanoma_Homo sapiens_hsa05218 | 0.42023186 |
148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41863515 |
149 | Mineral absorption_Homo sapiens_hsa04978 | 0.40284607 |
150 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39702447 |
151 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39201190 |
152 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38835886 |
153 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38713132 |
154 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37832241 |
155 | Salmonella infection_Homo sapiens_hsa05132 | 0.37363515 |
156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37015288 |
157 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36742692 |
158 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36606264 |
159 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36491191 |
160 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36055964 |
161 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35699471 |
162 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34157796 |